Patients with Gaucher type 1: Switching from imiglucerase to miglustat therapy
Ebru Canda(Ege University), Mahmut Çöker(Ege University), Mehtap Kağnıcı(Antalya Eğitim ve Araştırma Hastanesi), Sema Kalkan Uçar(Ege University), Eser Yıldırım Sözmen(Izmir University), Melis Köse(Children's Hospital of Philadelphia)
Cited by 6
Related Papers
A Phase 3 Trial of Sebelipase Alfa in Lysosomal Acid Lipase Deficiency
|New England Journal of Medicine|2015|244
An evaluation of quality of life of mothers of children with enuresis nocturna
|Pediatric Nephrology|2007|71
Efficacy and safety of empagliflozin in glycogen storage disease type Ib: Data from an international questionnaire
|Genetics in Medicine|2022|64